| Yang, Hua |
NCT04370925: Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis |
|
|
| Recruiting | 3 | 688 | RoW | Radical colectomy, HIPEC, Systemic chemotherapy | Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University | Colorectal Cancer | 04/24 | 04/26 | | |
NCT06419621: PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic Triple-negative Breast Cancer |
|
|
| Recruiting | 3 | 360 | RoW | PM8002, Nab-Paclitaxel, Placebo | Biotheus Inc. | Triple Negative Breast Cancer(TNBC) | 07/27 | 07/28 | | |
TQB2102-III-01, NCT06561607: A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer |
|
|
| Not yet recruiting | 3 | 542 | RoW | TQB2102 for Injection, Chemotherapy drug (Capecitabine/Paclitaxel/Albumin Paclitaxel) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Breast Cancer | 01/27 | 12/28 | | |
JSKN003-302, NCT06079983: JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects |
|
|
| Not yet recruiting | 3 | 400 | RoW | JSKN003, Capecitabine tablets, Gemcitabine hydrochloride for injection, Vinorelbine tartrate injection, Paclitaxel for injection (albumin-bound type), Docetaxel injection, Eribulin mesylate injection | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Breast Cancer | 04/25 | 03/29 | | |
| Recruiting | 3 | 314 | RoW | Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502), Control drug: Trastuzumab emtansine (Kadcyla, T-DM1) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Breast Cancer | 07/25 | 01/26 | | |
NCT06006689: Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis) |
|
|
| Recruiting | 2 | 228 | RoW | Qishen Yiqi Dripping Pills placebo 3 bags, Placebo group, Low dose Qishen Yiqi Dripping Pills 3 bags, Low dose group, High dose Qishen Yiqi Dripping Pills 3 bags, High dose group | Tasly Pharmaceutical Group Co., Ltd | Diabetic Kidney Disease | 09/25 | 09/25 | | |
NCT05438329: First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors |
|
|
| Recruiting | 1/2 | 902 | US, RoW | DB-1305/BNT325, DB-1305/BNT325 for Injection, Pembrolizumab, BNT327 | DualityBio Inc., BioNTech SE | Advanced Solid Tumor | 06/25 | 06/25 | | |
NCT06521931: A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients |
|
|
| Recruiting | 1 | 24 | RoW | PN20 | Chongqing Peg-Bio Biopharm Co., Ltd. | Thrombocytopenia | 12/24 | 12/24 | | |
NCT05362019: Effects of One-to-one Service on the Continuation and Satisfaction of Contraceptive Use. |
|
|
| Not yet recruiting | N/A | 400 | RoW | Compound Norethisterone Enanthate Injection, One-to-one Service, Family Planning Service | National Research Institute for Family Planning, China | Contraception Behavior, Contraceptive Usage | 12/22 | 03/23 | | |
FAST-EM, NCT06029153: Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable Migraine |
|
|
| Completed | N/A | 15 | RoW | Middle meningeal artery embolization | The Affiliated Hospital Of Guizhou Medical University | Migraine | 11/24 | 11/24 | | |
| Completed | N/A | 1000 | RoW | | Peking Union Medical College Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Vagina Disease, Vaginal Community State Type | 07/22 | 07/22 | | |
NCT00289380: Nutrition Support on Outcomes and Cost-effectiveness for Patients at Risk |
|
|
| Recruiting | N/A | 2000 | RoW | | Peking Union Medical College | Malnutrition, Nutritional Risk | 01/40 | 01/40 | | |
| Gao, Yongtao |
NCT06230965: Clinical Study of Lung Protective Ventilation Strategies and Tumor Microenvironment |
|
|
| Enrolling by invitation | N/A | 60 | RoW | Lung protective ventilation strategy, conventional ventilation strategy | Affiliated Hospital of Nantong University | Tumor Microenvironment | 08/25 | 12/25 | | |
NCT06732427: Clinical Study of Fospropofol Disodium for Injection in the Painless Endoscopic Diagnosis and Treatment |
|
|
| Not yet recruiting | N/A | 426 | RoW | fospropofol Disodium for injection, sulfentanyl, Propofol | Affiliated Hospital of Nantong University | Efficacy and Safety | 06/26 | 12/26 | | |
| Yuhua, Lu Y |
NCT05327400: Expression and Clinical Significance of IGHD in Pancreatic Cancer |
|
|
| Recruiting | N/A | 30 | RoW | Pathological | Affiliated Hospital of Nantong University | Gene Expression | 10/23 | 10/23 | | |
| Qiyang, Chen Q |
NCT05327400: Expression and Clinical Significance of IGHD in Pancreatic Cancer |
|
|
| Recruiting | N/A | 30 | RoW | Pathological | Affiliated Hospital of Nantong University | Gene Expression | 10/23 | 10/23 | | |
| Chen, Xiao-Lan |
| Active, not recruiting | 3 | 404 | Europe, Canada, Japan, US, RoW | Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo | Chinook Therapeutics, Inc. | IgA Nephropathy, Immunoglobulin A Nephropathy | 12/26 | 12/26 | | |
| Huang, Xinzhong |
NCT06470191: A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. |
|
|
| Recruiting | 2/3 | 216 | RoW | B007, Cyclosporin Capsules | Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd | Primary Membranous Nephropathy | 12/26 | 12/26 | | |
| Recruiting | 2 | 140 | RoW | WS016 3g, WS016 6g, WS016 12g, Matching Placebo | Waterstone Pharmaceutical (Wuhan) Co., LTD. | Hyperkalemia | 04/24 | 08/24 | | |
